These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11908765)

  • 21. Micro- and nano-fabricated implantable drug-delivery systems: current state and future perspectives.
    Meng E; Sheybani R
    Ther Deliv; 2014 Nov; 5(11):1167-70. PubMed ID: 25491666
    [No Abstract]   [Full Text] [Related]  

  • 22. Insights for the development of specific kinase inhibitors by targeted structural genomics.
    Fedorov O; Sundström M; Marsden B; Knapp S
    Drug Discov Today; 2007 May; 12(9-10):365-72. PubMed ID: 17467572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
    Mackonochie M
    IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
    [No Abstract]   [Full Text] [Related]  

  • 24. siRNAs in drug discovery: target validation and beyond.
    Natt F
    Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iconix Biosciences, Inc.
    Fielden MR; Halbert DN
    Pharmacogenomics; 2007 Apr; 8(4):401-5. PubMed ID: 17391077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will genomics revolutionise pharmaceutical R&D?
    Noble D
    Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel initiative seeks genetic causes of diabetes risk.
    Ratner M
    Nat Rev Drug Discov; 2004 Dec; 3(12):987. PubMed ID: 15645600
    [No Abstract]   [Full Text] [Related]  

  • 28. Seeing is believing--visualizing drug delivery in vitro and in vivo.
    Swartz H
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1085-6. PubMed ID: 15935867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
    Brown D
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical genomics comes of age.
    Wortman M
    Drug Discov Today; 2003 Aug; 8(15):678-80. PubMed ID: 12927510
    [No Abstract]   [Full Text] [Related]  

  • 31. Can cell systems biology rescue drug discovery?
    Butcher EC
    Nat Rev Drug Discov; 2005 Jun; 4(6):461-7. PubMed ID: 15915152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the discovery and delivery of vaccine adjuvants.
    O'Hagan DT; Valiante NM
    Nat Rev Drug Discov; 2003 Sep; 2(9):727-35. PubMed ID: 12951579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics drugs in clinical trials.
    Hall J; Dennler P; Haller S; Pratsinis A; Säuberli K; Towbin H; Walther K; Woytschak J
    Nat Rev Drug Discov; 2010 Dec; 9(12):988. PubMed ID: 21119735
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluorescence imaging: applications in drug delivery research.
    Agarwal A; Tripathi PK; Tripathi S; Jain NK
    Curr Drug Targets; 2008 Oct; 9(10):895-8. PubMed ID: 18855624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development.
    Hurko O
    Eur Neuropsychopharmacol; 2001 Dec; 11(6):491-9. PubMed ID: 11704426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine.
    Vizirianakis IS
    Eur J Pharm Sci; 2002 Apr; 15(3):243-50. PubMed ID: 11923056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer research 2001: drug resistance, new targets and drug combinations.
    Broxterman HJ; Georgopapadakou N
    Drug Resist Updat; 2001 Jun; 4(3):197-209. PubMed ID: 11768333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.